We use artificial intelligence and machine learning to advance medicines for both internal and external projects. Our primary business model is improving the success and efficiency of drug development which is accomplished either through acquisition of drugs or partnerships and collaborations with companies that are developing drugs.
$6.38 - $6.38
November 18, 2022
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277